Published in Gene Therapy Weekly, August 5th, 1996
"After an in-depth review of technical and scientific aspects of the liposome-CD4 technology ... we concluded that Sheffield's liposome-CD4 technology combined with Sequus's proprietary Stealth liposome technology presents a potentially promising new approach for treating HIV/AIDS," said I. Craig Henderson, M.D., Sequus.
"Existing data indicates that Stealth liposomes accumulate in peripheral lymphatic tissues, such as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.